These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37748967)

  • 1. Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
    Schwameis R; Fanfani F; Ebner C; Zimmermann N; Peters I; Nero C; Marth C; Ristl R; Leitner K; Grimm C; Oberndorfer F; Capasso I; Zeimet AG; Polterauer S; Scambia G; Fagotti A; Concin N
    Eur J Cancer; 2023 Nov; 193():113317. PubMed ID: 37748967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort.
    Yu C; Yuan X; Yao Q; Xu Y; Zhou X; Hu X; Yang H; Wang H; Zhu X; Ren Y
    BMC Cancer; 2024 Jul; 24(1):862. PubMed ID: 39026198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
    Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
    J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage distribution and prognostic accuracy of the 2023 FIGO (the International Federation of Gynecology & Obstetrics) staging system for endometrial cancer: A retrospective cohort study.
    Loukovaara M; Pasanen A; Bützow R
    Int J Gynaecol Obstet; 2024 Jun; ():. PubMed ID: 38922703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?
    Han KH; Park N; Lee M; Lee C; Kim H
    J Gynecol Oncol; 2024 Sep; 35(5):e59. PubMed ID: 38302727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients.
    Gaffney D; Suneja G; Weil C; Creutzberg C
    Pract Radiat Oncol; 2024 Jul; ():. PubMed ID: 39019210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
    Zivanovic O; Leitao MM; Iasonos A; Jacks LM; Zhou Q; Abu-Rustum NR; Soslow RA; Juretzka MM; Chi DS; Barakat RR; Brennan MF; Hensley ML
    J Clin Oncol; 2009 Apr; 27(12):2066-72. PubMed ID: 19255317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
    Raut CP; Nucci MR; Wang Q; Manola J; Bertagnolli MM; Demetri GD; Morgan JA; Muto MG; Fletcher CD; George S
    Eur J Cancer; 2009 Nov; 45(16):2818-24. PubMed ID: 19647426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
    Abu-Rustum NR; Zhou Q; Iasonos A; Alektiar KM; Leitao MM; Chi DS; Sonoda Y; Soslow R; Hensley M; Barakat RR
    Int J Gynecol Cancer; 2011 Apr; 21(3):511-6. PubMed ID: 21436699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma.
    Song T; Xu H; Shi L; Yan S
    Int J Womens Health; 2022; 14():333-344. PubMed ID: 35283649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for advanced endometrial cancer.
    Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer.
    Türkmen O; Karalok A; Başaran D; Kimyon G; Kul G; Tulunay G; Üreyen I; Turan T
    J Turk Ger Gynecol Assoc; 2017 Sep; 18(3):110-115. PubMed ID: 28890424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIGO 2023 endometrial cancer staging: too much, too soon?
    McCluggage WG; Bosse T; Gilks CB; Howitt BE; McAlpine JN; Nucci MR; Rabban JT; Singh N; Talia KL; Parra-Herran C
    Int J Gynecol Cancer; 2024 Jan; 34(1):138-143. PubMed ID: 37935523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
    Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
    [No Abstract]   [Full Text] [Related]  

  • 20. FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype.
    Haltia UM; Bützow R; Leminen A; Loukovaara M
    J Gynecol Oncol; 2014 Jan; 25(1):30-5. PubMed ID: 24459578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.